| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Freeline Therapeutics Holdings plc (NASDAQ: FRLN)
FRLN Technical Analysis
5
| As on 9th Jun 2023 FRLN STOCK Price closed @ 2.22 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.99 & Strong Buy for SHORT-TERM with Stoploss of 1.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FRLNSTOCK Price
| Open | 2.21 | Change | Price | % |
| High | 2.36 | 1 Day | -0.02 | -0.89 |
| Low | 2.21 | 1 Week | -0.28 | -11.20 |
| Close | 2.22 | 1 Month | 1.84 | 484.21 |
| Volume | 36137 | 1 Year | 0.09 | 4.23 |
| 52 Week High 3.33 | 52 Week Low 0.24 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FRLN Daily Charts |
FRLN Intraday Charts |
Whats New @ Bazaartrend |
FRLN Free Analysis |
|
|
FRLN Important Levels Intraday
| RESISTANCE | 2.51 |
| RESISTANCE | 2.42 |
| RESISTANCE | 2.36 |
| RESISTANCE | 2.30 |
| SUPPORT | 2.14 |
| SUPPORT | 2.08 |
| SUPPORT | 2.02 |
| SUPPORT | 1.93 |
FRLN Forecast April 2024
| 4th UP Forecast | 5.13 |
| 3rd UP Forecast | 4.2 |
| 2nd UP Forecast | 3.62 |
| 1st UP Forecast | 3.04 |
| 1st DOWN Forecast | 1.4 |
| 2nd DOWN Forecast | 0.82 |
| 3rd DOWN Forecast | 0.24 |
| 4th DOWN Forecast | -0.69 |
FRLN Weekly Forecast
| 4th UP Forecast | 2.80 |
| 3rd UP Forecast | 2.61 |
| 2nd UP Forecast | 2.50 |
| 1st UP Forecast | 2.38 |
| 1st DOWN Forecast | 2.06 |
| 2nd DOWN Forecast | 1.94 |
| 3rd DOWN Forecast | 1.83 |
| 4th DOWN Forecast | 1.64 |
FRLN Forecast2024
| 4th UP Forecast | 10.53 |
| 3rd UP Forecast | 7.86 |
| 2nd UP Forecast | 6.22 |
| 1st UP Forecast | 4.57 |
| 1st DOWN Forecast | -0.13 |
| 2nd DOWN Forecast | -1.78 |
| 3rd DOWN Forecast | -3.42 |
| 4th DOWN Forecast | -6.09 |
Freeline Therapeutics Holdings plc ( NASDAQ USA Symbol : FRLN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FRLN Business Profile
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is FLT180a, a gene therapy product candidate that is in Phase 1/2 dose-finding clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in dose-escalating Phase 1/2 clinical trials for the treatment of Fabry disease; FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease; and FLT210, a liver-directed gene therapy product candidate for the treatment of hemophilia A. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. Address: Stevenage Bioscience Catalyst, Stevenage, United Kingdom, SG1 2FX
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service